BOUGUEN, G., ROBLIN, X., BOURREILLE, A., FEIER, L., FILIPPI, J., NANCEY, S., … PEYRIN-BIROULET, L. (2010). Infliximab for refractory ulcerative proctitis. Alimentary Pharmacology & Therapeutics, 31(11), 1178–1185. doi:10.1111/j.1365-2036.2010.04293.x BACKGROUND: Efficacy of infliximab in treating ulcerative proctitis remains unknown. AIM: To evaluate the clinical, biological and endoscopic efficacy of infliximab therapy in refractory proctitis. METHODS: The ..
Tag : remicade
Infliximab switch to Adalimumab in Crohn Related articles (Crohn):*Azathioprine Crohn*Methotrexate in Crohn*Infliximab in Crohn (ACCENT I)*Infliximab with Azathiopurine (Crohn)*Infliximab with Methotrexate (Crohn)*Adalimumab (CLASSIC & CHARM trial – Crohn)*Adalimumab with immunomodulator (Crohn)*Ustekinumab (UNITI trial – Crohn – 2016)*Vedolizumab (GEMINI II – Crohn – 2013) Background and Aims: In the 4-week GAIN clinical trial, adalimumab was efficacious ..
Recent Comments